GROUP ONE TRADING, L.P. - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q2 2024$80,930
-52.4%
26,191
-60.3%
0.00%
-100.0%
Q1 2024$170,195
+831.0%
65,967
+802.2%
0.00%
Q4 2023$18,280
+52.3%
7,312
+19.6%
0.00%
Q3 2022$12,000
-67.6%
6,112
-55.8%
0.00%
Q2 2022$37,000
-93.3%
13,835
-92.6%
0.00%
-100.0%
Q1 2022$554,000
-60.3%
185,781
-48.2%
0.00%0.0%
Q4 2021$1,395,000
+28.9%
358,522
+42.1%
0.00%0.0%
Q3 2021$1,082,000
+389.6%
252,225
+246.3%
0.00%
Q2 2021$221,000
-46.7%
72,831
-41.5%
0.00%
-100.0%
Q1 2021$415,000
-64.4%
124,589
-62.1%
0.00%
-50.0%
Q4 2020$1,167,000
+407.4%
328,681
+346.8%
0.00%
+100.0%
Q3 2020$230,000
+3733.3%
73,561
+1243.3%
0.00%
Q1 2020$6,000
+20.0%
5,476
+74.4%
0.00%
Q3 2019$5,000
-44.4%
3,140
-30.9%
0.00%
Q2 2019$9,000
+28.6%
4,542
+155.0%
0.00%
Q4 2018$7,000
-94.3%
1,781
-91.0%
0.00%
-100.0%
Q3 2017$123,000
+151.0%
19,830
+46.4%
0.00%0.0%
Q2 2017$49,000
+104.2%
13,549
+81.6%
0.00%
Q1 2017$24,000
-78.2%
7,459
-83.4%
0.00%
-100.0%
Q4 2016$110,000
+35.8%
44,877
+91.1%
0.00%0.0%
Q3 2016$81,000
+88.4%
23,479
+89.7%
0.00%0.0%
Q2 2016$43,000
-40.3%
12,374
-29.1%
0.00%0.0%
Q1 2016$72,000
-20.0%
17,456
-13.8%
0.00%0.0%
Q4 2015$90,000
-81.2%
20,253
-74.2%
0.00%
-85.7%
Q3 2015$478,00078,5530.01%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q1 2020
NameSharesValueWeighting ↓
QVT Financial LP 16,013,540$39,233,0001.19%
ARMISTICE CAPITAL, LLC 1,940,000$4,753,0001.12%
DAFNA Capital Management LLC 234,000$573,0000.50%
Alpha Wave Global, LP 1,655,162$4,055,0000.43%
Telemetry Investments, L.L.C. 150,000$368,0000.21%
LADENBURG THALMANN FINANCIAL SERVICES INC. 5,294,945$12,972,0000.18%
SABBY MANAGEMENT, LLC 792,617$1,942,0000.11%
K2 PRINCIPAL FUND, L.P. 443,887$1,088,0000.10%
Anson Funds Management LP 105,085$257,0000.08%
DIALECTIC CAPITAL MANAGEMENT, LP 25,000$61,0000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders